Skip to main content
. 2017 Mar 13;2017(3):CD012286. doi: 10.1002/14651858.CD012286.pub2

NCT02203266.

Study name A randomised, parallel‐group, multi‐centre trial using a novel 'INCA' Tracker Device to measure and monitor compliance and technique of Seretide Diskus inhaler in a community pharmacy setting
Methods Open‐label parallel‐group randomised controlled trial
Participants Adults with asthma or COPD aged 18 years or older with a valid prescription for Seretide Diskus inhaler or currently using a Seretide Diskus inhaler. Planned recruitment 200 participants
Interventions Feedback on the participant's own inhaler use, with personalised information on participant technique and timing of use of the Diskus inhaler as recorded on the INCA device, will be provided to participants in the feedback group after 1, 2 and 6 months vs current best practice inhaler technique education
Outcomes Adherence, inhaler technique, rescue inhaled medication use, rescue antibiotic/steroid use, quality of life
Starting date February 2014
Contact information Richard Costello
Royal College of Surgeons
Clinical Research Centre
Beuamont Hospital
Email: rcostello@rcsi.ie
Notes